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Cost-Effectiveness of Guidelines for Insertion of Inferior Vena Cava
Filters in High-Risk Trauma Patients
E. L. Spangler, E. D. Dillavou, and K. J. Smith, Pittsburgh, Pa
From the University of Pittsburgh.
Background: Inferior vena cava filters (IVCF) can prevent pulmonary
embolism (PE); however, indications for use vary. While the Eastern Asso-
ciation for the Surgery of Trauma (EAST) 2002 guidelines suggest prophy-
lactic IVCF use in high-risk patients, the American College of Chest Physi-
cians (ACCP) 2008 guidelines do not. This analysis compared the cost-
effectiveness of prophylactic vs therapeutic retrievable IVCF placement in
high-risk trauma patients.
Methods: A Markov model was created to determine incremental
cost-effectiveness of these guidelines in dollars per quality-adjusted life-years
(QALYs) by accounting for costs and utilities of events occurring during
hospitalization and long-term follow-up. Our population was 46-year-old
trauma patients at high risk for venous thromboembolism (VTE) by EAST
criteria to whom either the EAST (prophylactic IVCF) or ACCP (no
prophylactic IVCF) guidelines were applied. The analysis assumed the
societal perspective over the patient’s lifetime, using a 1-day cycle length.
For base case and sensitivity analyses, event probabilities and utilities were
obtained from published literature, and costs calculated from the Center for
Medicare and Medicaid Services (CMS) fee schedules, the Healthcare Cost
and Utilization Project database, and Redbook wholesale drug prices for
2007; for data not available from the literature, assumptions were set forth
based on similarities to other populations.
Results: In base case analysis, prophylactic IVCFs were not cost-
effective, being bothmore costly ($37,700 vs $37,300) and less effective (by
0.139 QALYs) than therapeutic IVCFs. Results were sensitive to several
probabilities; the cost-effectiveness of prophylactic IVCFs varied signifi-
cantly with probabilities of late venous thromboembolism (VTE) and com-
plications related to anticoagulation. Prophylactic IVCFs were less effective,
but less costly when the probability of late VTE was 4.3% per year (base
case, 4.6%) among those with a removed filter, or5.1% per year (base case,
6.1%) among those with a retained filter. The probability of anticoagulation
complications, primarily gastrointestinal bleeding, was assumed to be the
same in individuals with removed filters and individuals who never had a
filter. Prophylactic filters were less effective, but less costly when the proba-
bility of anticoagulation complications among those with a removed filter or
who never had a filter was 3.9% per year (base case, 2.5%). Prophylactic
filters were less effective andmore costly over the range of probabilities in the
literature of anticoagulation complications for individuals with a retained
filter (base case, 2.1%/y).
Conclusions: Our analysis suggests prophylactic IVC filters are not
cost-effective. This result is dependent on probabilities of long-term se-
quelae (VTE, bleeding complications) that are poorly characterized in the
literature due to the recent advent of retrievable filters and lack of long-term
follow-up in patients with retained and removed filters.
Large Vein Reconstruction with Oncologic Procedures
M. A. Mansour, B. Wheatley, J. M. Gorsuch, C. A. Chambers, and
R. F. Cuff, Grand Rapids, Mich
From Michigan State University.
Background: Tumor proximity or invasion of large venous structures
in the abdomen frequently requires resection or reconstruction of large
veins. This study reviewed the outcomes of large vein reconstruction in
conjunction with surgical resection of intra-abdominal tumors.
Methods: In a 5-year period, 16 patients (2 women, 14 men) pre-
sented for resection of intra-abdominal malignancy. The average patient age
was 57 years (range, 41-67 years). Tumor proximity or invasion of large
venous structures was detected on preoperative computed tomography
(CT) scan. The groins were prepared in the surgical field to facilitate
harvesting of the great saphenous vein, if necessary. Venous reconstruction
with primary resection and reanastomosis or saphenous panel graft was
performed in all cases except one, where the entire infrarenal inferior vena
cava (IVC) was replaced with a polytetrafluoroethylene graft. Follow-up
imaging was done in all patients 3 months.
Results: Resection of tumors invading or adjacent to IVC was done in
eight patients, portal vein in seven, and iliac vein in one. For the IVC
patients, tissue pathology was renal cell carcinoma in five, leiomyoma in two,
and recurrent testicular cancer in one. Pancreatic adenocarcinoma caused all
the portal vein cases. Extracorporeal femoral–axillary venovenous bypass was
performed in three patients to help venous return during clamping. One
patient required hypothermic circulatory arrest to resect an intravascular
tumor that extended from the right iliac vein to the atrium. Reconstruction
of the portal vein was with primary repair in four and paneled saphenous vein
in three. The IVC was primarily repaired in all but one patient. The iliac vein
was repaired with paneled saphenous vein graft. All patients were alive in the
average follow-up period of 9 months (range, 1-60 months). The patient
with the prosthetic graft presented with a duodenal leak and graft infection
necessitating graft excision at 4 weeks. Recurrent pancreatic cancer was
detected in three patients. All venous structures except one were patent in
follow-up.
Conclusions: Large vein reconstruction is required in a small number
of patients to restore venous continuity. Primary repair or bypass with
autogenous graft is preferable to ligation or prosthetic graft. Most venous
reconstructions remain patent without any special anticoagulation.
Post-Menopausal Leg Swelling
S. Raju,a M. Oglesbee,b and P. Neglen,b Jackson and Flowood, Miss
From theUniversity ofMississippiMedical Center, Jacksona; and River Oaks
Hospital, Flowood.b
Background: Leg swelling after menopause is common. The prevail-
ing concept in primary care is that it is polycentric and a treatable cause may
not be found. Traditional systemic causes may be investigated, but venous
etiology is rarely considered. Patients are prescribed empiric diuretics, often
without benefit. Our clinical experience indicates that iliac venous vein
obstruction is frequently the core cause. A variety of secondary factors that
are common in the postmenopausal life stage (eg, joint surgery, onset of
venous reflux, venosclerosis, seated orthostasis) disturb the precarious re-
gional fluid balance and precipitate swelling. Postulated but undefined
hormonal and metabolic imbalances may be contributory.
Methods: Intravascular ultrasound (IVUS)-guided vein stenting im-
aging was done in 310 limbs of 256 postmenopausal women (aged 55
years) with leg swelling unresponsive to conservative therapy (49 with
concurrent endovenous laser therapy) during an 11-year period. The group
constituted 18% of the 1760 limbs with chronic venous disease stented
during the same period and 34% of those stented for swelling. Median age
was 66 years (range, 55-92 years) and the left/right ratio was 3:1.
Results: Obstruction was primary in 65% and post-thrombotic in 35%
of limbs. Thirty-one percent of limbs had obstruction only and 69% com-
bined obstruction and reflux: 32% had superficial reflux, 10% deep reflux,
and 24% had both. Axial reflux was present in 8%. Lymphatic dysfunction
was present in 13% of the limbs. Mean IVUS area stenosis was 70%  20%
(SD). The 30-day mortality was nil. Deep venous thrombosis occurred in
seven limbs 30 days and in five others later (overall, 4%). Mean follow-up
was 19  22 months (range, 1-120 months). Secondary stent patency at 6
years was 100% in primary and 78% in post-thrombotic limbs (91% overall).
Five of 14 stents that occluded were reopened. Swelling improved signifi-
cantly (P  .0001) from preoperative grade 2  1 to postoperative grade
1  1.2. Associated pain also improved significantly (P  .0001) from
preoperative VAS 4  3 to postoperative 0.6  1.7. Scores on the Chronic
Venous Insufficiency Quality of Life Questionnaire improved significantly
(P .0001) in every category (pain, work, sleep, social, morale) and overall
(from 66  20 preoperative to 49  22 postoperative; P  .0001).
Conclusions: Patients with post-menopausal leg swelling frequently
have obstructive venous pathology and two-thirds have associated reflux.
Morbidity arises from painful swelling that retards mobility and compro-
mises ability of self-care at a frail stage of life. Characteristic clinical features
and pathology should qualify this large subset as a distinct clinical entity.
Outpatient percutaneous iliac vein stenting alone or with concurrent saphe-
nous ablation affords substantial symptom relief and improvement in quality
of life measures. Greater clinical awareness among primary care physicians is
essential to serve this otherwise neglected patient population.
Neonatal and Adult Dermal Fibroblasts Show Differences in Transform-
ing Growth Factor (TGF-) Secretion and TGF- Type II Receptor
Expression at Baseline and Under Constant Stretch Conditions
C. Glass, J. Cullen, E. Roztocil, C. Doan, G. Augustin, K. Illig, M. Singh,
and D. Gillespie, Rochester, NY
From the University of Rochester.
Background: Previous investigations in dysregulation of tissue fibrosis
seen in chronic venous insufficiency (CVI) have used commercially available
neonatal fibroblasts (nn-fbs) as controls. Adult fibroblasts (a-fbs) are com-
mercially available but have not been used as controls to study venous
disease, which occurs predominantly in the adult population. In an effort to
investigate if transforming growth factor (TGF)- alterations occur as a
normal process in healthy aging fibroblasts, we examined TGF-, TGF-RI,
and TGF-RII expression between commercial nn-fbs and a-fbs. We also
attempted to determine if there were any differences in response to mechan-
ical stress between healthy nn-fbs and a-fbs.
Methods: Confluent early passage (P3-P5) nn-fbs and a-fbs were
cultured. Flow cytometry by fluorescence activated cell sorting (FACS) was
performed to determine basal levels of TGF-RI-positive and TGF-RII-
positive cells and receptor density measured by mean fluorescent intensity
(MFI). Basal levels of secreted TGF- were quantified using enzyme-linked
immunosorbent assay (ELISA). To mimic the increased stretch to which
dermal fibroblasts are exposed to in patients with CVI, nn-fbs and a-fbs were
cultured on collagen-coated Flexplates, and subjected to constant equibi-
axial elongation (21%) for 24 hours using a Flexercell strain unit. Cells and
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